GlassScriptPhysician profile
Alaina Geren
NPI 1790272417
$4,483.48
in general payments reported to CMS, 2019-2025
16 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $366 · 2023: $441 · 2024: $1,978 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,696 · Travel and Lodging: $415 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,695.93 |
| Travel and Lodging | $414.51 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,170.36 | 2022-2025 | Clareon, Clareon Panoptix Pro, Acrysof Iq Vivity |
| Biotissue Holdings INC. | $559.15 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $417.21 | 2024-2025 | Xiidra, Stellaris, Envista Mx60 Iol |
| Glaukos Corporation | $235.98 | 2022-2025 | Kxl System (Not Refurbished), Photrexa Cross-Linking Kit |
| Ani Pharmaceuticals, INC. | $199.22 | 2024-2025 | Iluvien, Yutiq, Purified Cortrophin Gel |
| Dompe US, INC. | $182.36 | 2024-2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $159.91 | 2023-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $151.79 | 2023-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $108.71 | 2025 | Tecnis Simplicity |
| Alimera Sciences, INC. | $97.42 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $54.83 | 2024-2025 | Xdemvy |
| Genentech USA, INC. | $44.41 | 2024-2025 | Vabysmo |
| Carl Zeiss Meditec USA, INC. | $40.32 | 2024 | Iolmaster 700 |
| Apellis Pharmaceuticals, INC. | $28.54 | 2025 | Syfovre |
| Amgen INC. | $18.95 | 2025 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $14.32 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alaina Geren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.